Role
Principal Investigator
Description
We will construct a proteome microarray of Schistosoma haematobium proteins to identify vaccine and diagnostic antigens for African schistosomiasis. Vaccine antigens will be prioritised and tested in collaboration with the Sabin Vaccine Institute, and diagnostic antigens will be developed in a funded partnership with Merck. Merck are also contributing funds to this project.
Date
01 Jul 2016 - 30 Jun 2019
Project Type
GRANT
Keywords
Blood fluke;Schistosomiasis;Diagnostic;Vaccine;Proteins;Neglected Tropical Disease
Funding Body
Department of Industry, MERCK
Amount
1082000
Project Team
Mark Pearson;Luke Becker